Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Drug development in paediatric oncology].

G Benninger-Döring1, J Boos

  • 1Universitätsklinikum Münster, Klinik und Poliklinik für Kinder- und Jugendmedizin, Pädiatrische Hämatologie/Onkologie, Münster.

Klinische Padiatrie
|May 12, 2006
PubMed
Summary

Pediatric cancer cure rates are high, but many drugs are used off-label. Pre-clinical screening and networking can accelerate drug development for children, reducing off-label use.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extended induction chemotherapy does not improve the outcome for high-risk neuroblastoma patients: results of the randomized open-label GPOH trial NB2004-HR.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

Quality assurance in CT: implementation of the updated national diagnostic reference levels using an automated CT dose monitoring system.

Clinical radiology·2018
Same author

Iterative metal artefact reduction in CT: can dedicated algorithms improve image quality after spinal instrumentation?

Clinical radiology·2017
Same author

Facet tropism and facet joint orientation: risk factors for the development of early biochemical alterations of lumbar intervertebral discs.

Osteoarthritis and cartilage·2016
Same author

Dose Monitoring in Radiology Departments: Status Quo and Future Perspectives.

RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin·2016
Same author

Asymmetrical flow field-flow fractionation for the analysis of PEG-asparaginase.

Talanta·2015

Area of Science:

  • Pediatric Oncology
  • Drug Development
  • Clinical Trials

Context:

  • Over 75% cure rates in childhood cancer are achieved today.
  • However, 60-90% of drugs used in pediatric oncology are prescribed off-label.
  • This highlights a significant gap in targeted pediatric drug availability.

Purpose:

  • To explore strategies for improving drug selection and development for pediatric cancer.
  • To leverage upcoming EU regulations and foster collaboration among research institutions.
  • To reduce the incidence of off-label drug use in treating childhood cancers.

Summary:

  • Comprehensive pre-clinical screening of drug candidates can create prioritized lists for pediatric use.
  • New EU regulations and increased networking among institutions can boost pediatric clinical trials.
  • Establishing robust networks can attract pharmaceutical partnerships, aiming to decrease off-label prescribing.

Impact:

  • Accelerated development of targeted therapies for pediatric cancer patients.
  • Enhanced collaboration between research societies, trial groups, and the pharmaceutical industry.
  • Significant reduction in off-label medication use, improving treatment safety and efficacy for children with cancer.

Related Experiment Videos